Morphine-Methadone Opioid Rotation in Cancer Patients: Analysis of Dose Ratio Predicting Factors

Journal of Pain and Symptom Management

Volumn 37, Issue 6, 2009, Pages 1061-1068

  Benítez Rosario, Miguel Angel ^a,b   Salinas Martín, Antonio ^a   Aguirre Jaime, Armando ^a   Pérez Méndez, Lina ^a   Feria, Manuel ^b  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

methadone; Morphine; opioid rotation; predicting factors

Indexed keywords

METHADONE; MORPHINE; OPIATE;

ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PATIENT; DELIRIUM; DOSE CALCULATION; DRUG DOSE ESCALATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG USE; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCLONUS; NEUROTOXICITY; PREDICTION; ROTATION; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN, INTRACTABLE; PALLIATIVE CARE; PREDICTIVE VALUE OF TESTS;

EID: 66149100087     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2008.05.016     Document Type: Article

References (35)

1. Mercadante S. Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 86 (1999) 1856-1866
2. Mancini I., Lossignol D.A., and Body J.J. Opioid switch to oral methadone in cancer pain. Curr Opin Oncol 12 (2000) 308-313
3. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 3 (2004) CD004847
4. Morita T., Takigawa C., Onishi H., et al. Japan Pain, Rehabilitation, Palliative Medicine, and Psycho-Oncology (PRPP) Study Group. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial. J Pain Symptom Manage 30 (2005) 96-103
5. Ripamonti C., and Bianchi M. The use of methadone for cancer pain. Hematol Oncol Clin North Am 16 (2002) 543-555
6. Lawlor P.G., Turner K.S., Hanson J., and Bruera E.D. Dose ratio between morphine and methadone in patients with cancer pain. A retrospective study. Cancer 82 (1998) 1167-1173
7. Ripamonti C., Groff L., Brunelli C., et al. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?. J Clin Oncol 16 (1998) 3216-3221
8. Cherny N., Ripamonti C., Pereira J., et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19 (2001) 2542-2554
9. Mercadante S., Cassucio A., Fulfaro F., et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 19 (2001) 2898-2904
10. Bruera E., and Sweeney C. Methadone use in cancer patients with pain: a review. J Palliat Med 5 (2002) 127-138
11. Indelicato R.A., and Portenoy R.K. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 21 Suppl 9 (2003) 87-91
12. Pereira J., Lawlor P., Vigano A., Dorgan M., and Bruera E. Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage 22 (2001) 672-687
13. Soares L.G.L. Methadone for cancer pain: what have we learned from clinical studies?. Am J Hosp Palliat Med 22 (2005) 223-227
14. Kaiko R.F., Wallenstein S.L., Rogers A.G., and Houde R.W. Sources of variation in analgesic responses in cancer patients with chronic pain receiving morphine. Pain 15 (1983) 191-200
15. Hall S., Gallagher R.M., Gracely E., Knowlton C., and Wescules D. The terminal cancer patient. Effects of age, gender, and primary tumor site on opioid dose. Pain Med 4 (2003) 125-134
16. Cepeda M.S., and Carr D.B. Women experience more pain and require more morphine than men to achieve a similar degree of analgesia. Anesth Analg 97 (2003) 1464-1468
17. Mercadante S., Cassucio A., Pumo S., and Fulfaro F. Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender. Support Care Cancer 8 (2000) 123-130
18. Viganó A., Bruera E., and Suarez-Almazor M.E. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 83 (1998) 1244-1250
19. Unruh A.M. Gender variations in clinical pain experience. Pain 65 (1996) 123-167
20. Rees W.D. Opioid needs of terminal care patients: variations with age and primary site. Clin Oncol (R Coll Radiol) 2 (1990) 79-83
21. Klepstad P., Dale O., Kaasa S., et al. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiol Scand 47 (2003) 725-731
22. Hanks G.W., and Reid C. Contribution to variability in response to opioids. Support Care Cancer 13 (2005) 145-152
23. Ventafridda V., Oliveri E., Caraceni A., et al. A retrospective study on the use of oral morphine in cancer pain. J Pain Symptom Manage 2 (1987) 77-81
24. Bercovitch M., Waller A., and Adunsky A. High dose morphine use in the hospice setting. A database survey of patient characteristics and effect of life expectancy. Cancer 86 (1999) 871-877
25. Ventafridda V., Saita L., Barletta L., Sbanotto A., and De Conno F. Clinical observations on controlled-release morphine in cancer pain. J Pain Symptom Manage 4 (1989) 124-129
26. Mercadante S., Cassucio A., Agnello A., and Barresi L. Methadone response in advanced cancer patients followed at home. J Pain Symptom Manage 18 (1999) 188-192
27. De Conno F., Groff L., Brunelli C., et al. Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol 14 (1996) 2836-2842
28. Daeninck P.J., and Bruera E. Opioid use in cancer pain. Is a more liberal approach enhancing toxicity?. Acta Anaesthesiol Scand 43 (1999) 924-938
29. Mercadante S., Ferrera P., Villari P., and Arcuri E. Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage 26 (2003) 769-775
30. Chu L.F., Clark D.J., and Angst M.S. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 7 (2006) 43-48
31. Ossipov M.H., Lai J., King T.W., et al. Antinociceptive and nociceptive actions of opioids. J Neurobiol 61 (2004) 126-148
32. Koppert W. Opioid-induced hyperalgesia-pathophysiology and clinical relevance. Acute Pain 9 (2007) 21-34
33. Ripamonti C., DeConno F., Groff L., et al. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ann Oncol 9 (1998) 79-83
34. Gorman A.L., Elliott K.J., and Inturrisi C.E. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett 223 (1997) 5-8
35. Eap C.B., Buclin T., and Baumann P. Interindividual variability of clinical pharmacokinetics of methadone. Clin Pharmacokinet 41 (2002) 1153-1193